drugset / Trial / NCT02217332
Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
NaSingle-groupOpen-labelTreatment
Summary
Phase 2, open-label, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 6 months in subjects with chronic sinusitis with nasal polyps and eosinophilia.
Timeline
- Start
- 2014-08
- Primary completion
- 2016-12-14
- Completion
- 2017-01-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexpramipexole | Small molecule | 150 mg | Oral |